A new sequential conditioning regimen based on CPX- 351/Vyxeos ("Vyx-Seq") in patients with higher risk myelodysplastic syndromes.
A B NotarantonioG Roth-GuépinC BonmatiM DivouxC KickiS PagliucaA CampidelliM T RubioM D'Aveni-PineyPublished in: Leukemia research (2023)